Conference AFPS 2023

Asian Federation for Pharmaceutical Sciences 2023
"Collaboration for Breakthroughs in Pharmaceutical Sciences"

November 8 - 10, 2023 | Hanoi, Viet Nam

ANNOUNCEMENT: Normal Registration extends to September 30th 2023 and we continue receiving abstracts for poster-presentation.!





Sponsor name

Sponsor category

Sponsor introduction

(100 words/ sponsor – maximum)

Sponsor logo

International Pharmaceutical Companies/ Representatives/ Enterprises


Pierre Fabre Foundation

Gold sponsor

The mission of the Fondation Pierre Fabre, which is a public interest organisation, is to provide access to quality medicines and care for the populations of the low and middle-income countries (LMICs) or in emergency situations. Having professionals trained to the highest level is a key element in the fight against substandard or falsified medicines and in strengthening health systems.

Since its creation in 1999, the Fondation Pierre Fabre has financed postgraduate training (master’s, PhD) and ongoing education of many pharmacists in Africa and Asia. After supporting master's courses in Vietnam, Laos and Cambodia between 2012 and 2019, it has committed itself from 2020 to support ongoing training in the form of workshops and shared research projects within the Mekong Pharma Network made up of the four universities of Hanoi (HUP), HCMC (UMP), Vientiane (UHS) and Phnom Penh (UHS).

The Fondation Pierre Fabre has chosen to support the organization of the "7th Conference of the Asian Federation for Pharmaceutical Sciences" because of its strategic importance as a place for scientific interaction and discussion for teachers and researchers in the Mekong Pharma Network, who will be able to meet up with and learn from their counterparts from other Asian countries and scientists working in the pharmaceutical industry.


Nagai Foundation

Silver sponsor

The Nagai Foundation Tokyo was founded on October 25, 1986 in commemoration of Prof. Tsuneji Nagai receiving the 1986 Hoest-Madsen Medal from FIP (International Pharmaceutical Federation) as the first for Japanese. The Japanese Ministry of Education, Culture, Sports, Science and Technology officially approved the Foundation as a government-licensed international one on January 28, 1994 and additionally as a specified non-profit organization for the benefit of the public on November 29, 1996 for the purpose of promoting international exchange in pharmacy and pharmaceutical sciences.


Vinif Foundation

Bronze sponsor

Vingroup Innovation Foundation (VINIF) was established in August 2018. For the first time, a private foundation funded the development of science and technology of the country in a completely non-profit way. VINIF aims towards supporting scientists and young talents from universities and institutes to create world-class scientific, technological and innovative researches in the field of Science, Technology, Engineering, Medicine, Economics and Education, in order to bring about positive and sustainable changes for Vietnam.After four years of implementation, VINIF has ponsored and managed around 110 science, technology and cultural history projects; Given 1.150 scholarships; Cooperate 06 training projects for Master of Data Science; Organized and sponsored approximately 130 scientific and technological conferences, events with total funding up to more than VND 750 billion. VINIF has built a VINIF Alumni Club with more than 1,000 young scientists who have received VINIF scholarships, hoping to contribute to creating a scientific research culture with high international standards.

VINIF's sponsorship programs include:

- Science and Technology Project Sponsorship Program

- Cooperation and Sponsorship for Events and Conferences

- Short-term Course and Visiting Professor Sponsorship

- Student Scholarships

- Postgraduate Scholarships

- Domestic Postdoctoral Fellowship

- Sponsorship and cooperative training

- Preserve Cultural and Historical Values

Find out more at



Gold sponsor

Pharma Group – the Pharmaceutical Sector Committee of EuroCham – represents the voice of the international research-based pharmaceutical industry in Vietnam. Pharma Group currently has 22 members who all share the vision of ensuring patients in Vietnam have fast and sustainable access to high quality, safe and innovative medicines.



Gold sponsor

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Our purpose is to reimagine medicine to improve and extend people’s lives. We deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. About 103,000 people of more than 140 nationalities work together to bring Novartis products to nearly 800 million people around the world. Find out more at


Astra Zeneca

Silver sponsor

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Having accompanied Vietnam for nearly three decades, AstraZeneca is investing into Vietnam 310 million USD from 2020 to 2030 with a focus on reducing the burdens of non-communicable diseases, developing local talent, and uplifting the domestic biopharmaceutical R&D and manufacturing capabilities.



Bronze sponsor

GSK is a global biopharma company. Our purpose is to unite science, technology and talent to get ahead of disease together and positively impact the health of 2.5 billion people. We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease.. GSK focuses on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

GSK launched its new legal entity in Vietnam in 2022, GSK Pharma Viet Nam Company Limited,  establishing its USD 200 million investment capital in the country, aims to growing sustainably and responsibly in Vietnam. . GSK Vietnam expressed its commitment to continue to work together with strategic healthcare partners in preventing and treating diseases with innovative vaccines and general medicines, positively impact the health of more than one third of Vietnamese population in the next three years.


 LMS Technologies Vietnam


LMS Technologies Vietnam is under LMS Group, headquartered in Singapore and 4 ASEAN countries: Malaysia, Thailand, Vietnam, and Indonesia.

Over 25 years of establishment and development, we are honored to consult and support customers in specialized laboratory equipment from R&D to QC for Material Science.

With our desire to be a “One-Stop Solution Provider” to our customers, we distribute a wide range of science instruments from principals who are market leaders worldwide with a strong reputation for quality and service support.

We are committed to meeting the challenge of our customers’ needs for testing & analysis, training, ISO qualifications, applications, and technical issues.

Local Pharmaceutical Companies/ Representatives/ Enterprises



Gold sponsor

Traphaco Joint Stock Company is the leading company of Vietnam’s pharmaceutical industry, specializing in manufacturing and trading pharmaceuticals, medicinal herbs, supplements and cosmetics, serving the needs of medical examination, treatment, and health care of the people through medical examination and treatment facilities, agents, and retail pharmacies nationwide.

Currently, Traphaco is the second largest listed pharmaceutical company in terms of revenue and profit in the pharmaceutical industry, with a strong brand name and a nationwide distribution system. We own many best selling herbal drugs in Vietnam; with a "win-win" business perspective, harmonizing the interests of all parties.

During half a century of development, Traphaco has increasingly improved the comprehensive quality management system: GPs-WHO, ISO, ISO; Enterprises have applied more management systems on digital platforms, gradually becoming Pharmaceutical Enterprise 4.0: DMS software for distribution system management, ERP - enterprise resource management, modern manufacturing technology.